Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Cardinal Health, Inc.    CAH

CARDINAL HEALTH, INC.

(CAH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/13/2020 01/14/2020 01/15/2020 01/16/2020 01/17/2020 Date
50.44(c) 52.45(c) 53.81(c) 54.42(c) 53.93(c) Last
2 526 564 3 186 256 4 023 233 2 710 293 2 566 369 Volume
-0.38% +3.98% +2.59% +1.13% -0.90% Change
More quotes
Financials (USD)
Sales 2020 153 B
EBIT 2020 2 279 M
Net income 2020 -2 875 M
Debt 2020 4 658 M
Yield 2020 3,70%
Sales 2021 159 B
EBIT 2021 2 303 M
Net income 2021 1 075 M
Debt 2021 2 246 M
Yield 2021 3,85%
P/E ratio 2020 -5,58x
P/E ratio 2021 14,3x
EV / Sales2020 0,13x
EV / Sales2021 0,11x
Capitalization 15 774 M
More Financials
Company
Cardinal Health is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows: - distribution of pharmaceutical products (88.6%); - distribution of medical, surgical and laboratory products (11.4%).... 
Sector
Drug Retailers
Calendar
02/06Earnings Release
More about the company
Surperformance© ratings of Cardinal Health, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDINAL HEALTH, INC.
01/20UN's decarbonisation target for shipping to cost over $1 trillion - study
RE
01/17BT, Vodafone may seek Johnson's support for Huawei - sources
RE
01/17CARDINAL HEALTH : FDA - Statement on quality issues with certain Cardinal Health..
AQ
01/16Apollo, Greybull, LOT to bid for Thomas Cook airline Condor -source
RE
01/16Defying U.S. sanctions, Iran boosts gasoil sales to neighbours
RE
01/15SHAREHOLDER ALERT : Robbins LLP is Investigating the Officers and Directors of C..
BU
01/15French strikes hit production at livestock feed factories
RE
01/15Fashion retailer Truworths posts slight 26-week sales gain
RE
01/13Oklahoma State Sues Drug Distributors Over Alleged Role in Opioid Crisis
DJ
01/13Pennon soars on report of rejecting KKR bid for unit Viridor
RE
01/09Dixons Carphone fined for systemic failures that led to cyber attack - ICO
RE
01/09Airbus boosts output at U.S. plant amid tariff dispute
RE
01/09TAKEAWAY SHAREHOLDERS APPROVE JUST E : company
RE
01/08South Africa's struggling Eskom to cut power overnight
RE
01/07Impact of French pensions strike on oil sector
RE
More news
News in other languages on CARDINAL HEALTH, INC.
04:42aOLIVIER BRANDICOURT : Adieu Diabetes - Weichenstellung an der Seine
2019CARDINAL HEALTH : Ex-dividend day for
2019Kepler Cheuvreux hebt Ziel für Sanofi auf 96 Euro - 'Buy'
2019AKTIEN IM FOKUS : US-Pharmawerte auf Talfahrt - WSJ: Untersuchung wegen Opioiden
2019Opioid-Krise - Reckitt zahlt Vergleich, J&J muss Gewinn um 3 Mrd senken
More news
Analyst Recommendations on CARDINAL HEALTH, INC.
More recommendations
Sector news : Drug Retailers - NEC
01/16Sinopharm to Raise HK$4 Billion via Sale of H Shares
DJ
01/13Oklahoma State Sues Drug Distributors Over Alleged Role in Opioid Crisis
DJ
01/13MCKESSON : Raises FY20 Adjusted EPS Guidance
DJ
01/10WALGREENS BOOTS ALLIANCE : Correction to Walgreens Boots Alliance Data Talk on W..
DJ
01/09Tesco outstrips retail rivals with Christmas sales rise
RE
More sector news : Drug Retailers - NEC
Chart CARDINAL HEALTH, INC.
Duration : Period :
Cardinal Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARDINAL HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Average target price 51,88  $
Last Close Price 53,93  $
Spread / Highest target 3,84%
Spread / Average Target -3,81%
Spread / Lowest Target -16,6%
EPS Revisions
Managers
NameTitle
Michael C. Kaufmann Chief Executive Officer & Director
Gregory B. Kenny Non-Executive chairman
David C. Evans Chief Financial Officer
Brian S. Rice Chief Information Officer & Executive VP
Calvin Ramarro Darden Independent Director
Sector and Competitors